Alzamend Neuro’s Phase 1/2A lithium neuroimaging data accepted for poster
Alzamend Neuro’s Phase 1/2A lithium neuroimaging data has been accepted for poster presentation at Neuroscience 2026 in Washington, DC, per Newsdesk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.